Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0030685,
umls-concept:C0032521,
umls-concept:C0032582,
umls-concept:C0034694,
umls-concept:C0035647,
umls-concept:C0178795,
umls-concept:C0185125,
umls-concept:C0391871,
umls-concept:C0443252,
umls-concept:C0597192,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1705480,
umls-concept:C1963578,
umls-concept:C2587213
|
pubmed:issue |
12
|
pubmed:dateCreated |
1985-4-10
|
pubmed:abstractText |
Based on drug release by microporous hollow fibers and the recent introduction of microporous polymers, a new technique was developed for controlled delivery of peptides. Small-diameter microporous polypropylene tubing, lumen-loaded with microgram quantities of vasopressin, and coated with collodion, releases vasopressin after in vitro immersion slowly (1-100 ng/d) and constantly for months. The mechanism of pseudo-zero-order delivery is based on high adsorption of vasopressin, keeping the void volume concentration of dissolved vasopressin constant, which is consequently a constant driving force of outward diffusion. The collodion coating prevents the entry of proteinaceous compounds which would result in rapid desorption of vasopressin. The present delivery module provides a lasting release for other peptides as well (lysine-vasopressin, oxytocin, alpha-melanocyte-stimulating hormone and, to a lesser extent, Met-enkephalin). The microporous polymer-collodion device is biocompatible and, loaded with vasopressin, successfully alleviates the diabetes insipidus of Brattleboro rats deficient for vasopressin. Subcutaneous implantation normalized diuresis for a period of 60 d and constant urine vasopressin excretion is observed. When the commercially available osmotic minipump is too large for implantation, the small size of the present controlled-delivery system allows peptide treatment of young and immature laboratory rats, even if located in utero.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Implants,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Polymers,
http://linkedlifedata.com/resource/pubmed/chemical/Polypropylenes,
http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-3549
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1713-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6527241-Animals,
pubmed-meshheading:6527241-Delayed-Action Preparations,
pubmed-meshheading:6527241-Diuresis,
pubmed-meshheading:6527241-Drug Implants,
pubmed-meshheading:6527241-Female,
pubmed-meshheading:6527241-Iodine Radioisotopes,
pubmed-meshheading:6527241-Polymers,
pubmed-meshheading:6527241-Polypropylenes,
pubmed-meshheading:6527241-Pregnancy,
pubmed-meshheading:6527241-Rats,
pubmed-meshheading:6527241-Rats, Brattleboro,
pubmed-meshheading:6527241-Rats, Inbred Strains,
pubmed-meshheading:6527241-Time Factors,
pubmed-meshheading:6527241-Vasopressins
|
pubmed:year |
1984
|
pubmed:articleTitle |
Controlled long-term release of small peptide hormones using a new microporous polypropylene polymer: its application for vasopressin in the Brattleboro rat and potential perinatal use.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|